In this study, the effects of Kinesio Taping methods applied in combination with Schroth therapy on pain and functional capacity in young adults diagnosed with idiopathic scoliosis will be evaluated.
This study is designed as a randomized controlled trial. Participants will be randomly assigned to one of three groups:
Group 1: Schroth therapy combined with Kinesio Taping
Group 2: Schroth therapy alone
Group 3: Schroth therapy combined with sham Kinesio Taping
Kinesio Taping will be applied for 4 weeks. The tape will remain in place for 5 consecutive days, followed by a 2-day rest period for the skin, and this cycle will be repeated throughout the intervention period.
Schroth therapy will be administered 3 times per week for 4 weeks.
Assessments will be conducted at baseline (Week 0), during treatment (Week 2), at the end of treatment (Week 4), and at follow-up (Week 8).
The primary outcome measures will be pain intensity assessed by the Numeric Rating Scale (NRS) and functional disability assessed by the Oswestry Disability Index (ODI). Secondary outcome measures will include the Scoliosis Research Society-22 (SRS-22) questionnaire and the Patient Global Impression of Change (PGIC) scale.
Individuals aged between 18 and 30 years.
Radiologically confirmed diagnosis of idiopathic scoliosis.
Cobb angle between 10° and 30° and considered candidates for conservative treatment.
Risser stage 5.
Diagnosis of non-structural (functional) scoliosis, congenital scoliosis, or neuromuscular scoliosis.
History of previous spinal surgery.
Participation in scoliosis-specific exercise therapy within the last 6 months.
Presence of open wounds, dermatological conditions, or allergy to taping materials.